Circulating osteoprotegerin is increased in the metabolic syndrome and associates with subclinical atherosclerosis and coronary arterial calcification
- Resource Type
- Article
- Source
- In
Clinical Biochemistry December 2014 47(18):272-278 - Subject
- Language
- ISSN
- 0009-9120